T cell suppression in the bone marrow of visceral leishmaniasis patients: impact of parasite load

被引:9
|
作者
Kumar, P. [1 ,2 ]
Misra, P. [1 ]
Thakur, C. P. [3 ]
Saurabh, A. [1 ,2 ]
Rishi, N. [2 ]
Mitra, D. K. [1 ]
机构
[1] AIIMS, Dept TII, New Delhi, India
[2] Amity Univ, Amity Inst Virol & Immunol, Noida, India
[3] Balaji Utthan Sansthan, Patna, Bihar, India
关键词
bone marrow aspirate (BMA); Leishmania donovani; T regulatory cells (T-reg); visceral leishmaniasis (VL); DIAGNOSIS;
D O I
10.1111/cei.13074
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Visceral leishmaniasis (VL) is a disseminated and lethal disease of reticulo-endothelial system caused by protozoan parasites Leishmania donovani and L. infantum, which are known to induce host T cell suppression. To understand the impact of parasite load on T cell function, the present was focused on parasite load with T cell function in bone marrow of 26 VL patients. We observed significant enrichment of forkhead box protein 3 (FoxP3)(+) (P = 0.0003) and interleukin (IL)-10(+) FoxP3(+) regulatory T cells (T-reg) (P = 0.004) in the bone marrow (BM) of patients with high parasite load (HPL) compared with low parasite load (LPL). Concordantly, T effector cells producing interferon (IFN)-gamma (P = 0.005) and IL-17A (P = 0.002) were reduced in the BM of HPL. Blocking of T-reg-cell derived suppressive cytokines [(IL-10 and transforming growth factor (TGF)-beta] rescued the effector T cells and their functions. However, it was observed that TGF-beta levels were dominant, favouring T-reg cell differentiation. Furthermore, the low ratio of IL-6/TGF-beta favours the suppressive milieu in HPL patients. Here we show the change in levels of various cytokines with the parasitic load during active VL, which could be helpful in devising newer immunotherapeutic strategies against this disease.
引用
收藏
页码:318 / 327
页数:10
相关论文
共 50 条
  • [21] Azacitidine-induced reconstitution of the bone marrow T cell repertoire is associated with superior survival in AML patients
    Grimm, Juliane
    Simnica, Donjete
    Jaekel, Nadja
    Paschold, Lisa
    Willscher, Edith
    Schulze, Susann
    Dierks, Christine
    Al-Ali, Haifa Kathrin
    Binder, Mascha
    BLOOD CANCER JOURNAL, 2022, 12 (01)
  • [22] Transgenic T cell-specific expression of CXCR3 enhances splenic and hepatic T cell accumulation but does not affect the outcome of visceral leishmaniasis
    Varikuti, Sanjay
    Natarajan, Gayathri
    Oghumu, Steve
    Sperling, Rachel H.
    Moretti, Ellen
    Stock, James
    Papenfuss, Tracey L.
    Satoskar, Abhay R.
    CELLULAR IMMUNOLOGY, 2016, 309 : 61 - 68
  • [23] Biological Features and Prognostic Impact of Bone Marrow Infiltration in Patients with Diffuse Large B-cell Lymphoma
    Alonso-Alvarez, Sara
    Alcoceba, Miguel
    Garcia-Alvarez, Maria
    Blanco, Oscar
    Rodriguez, Marta
    Baile, Monica
    Carlos Caballero, Juan
    Davila, Julio
    Belen Vidriales, Maria
    Esteban, Carmen
    Arias, Piedad
    Diaz, Luis G.
    Tamayo, Pilar
    Dolores Caballero, Maria
    Gutierrez, Norma C.
    Gonzalez, Marcos
    Martin, Alejandro
    CANCERS, 2020, 12 (02)
  • [24] Leishmania donovani skews the CD56+ Natural Killer T cell response during human visceral leishmaniasis
    Kumari, Santa
    Jamal, Fauzia
    Shivam, Pushkar
    Thakur, Ajit
    Kumar, Manish
    Bimal, Sanjiva
    Das, V. N. R.
    Pandey, K.
    Narayan, S.
    Gupta, A. K.
    Das, P.
    Singh, Shubhankar K.
    CYTOKINE, 2015, 73 (01) : 53 - 60
  • [25] Peripheral blood mononuclear cells of patients with Indian visceral leishmaniasis suppress natural killer cell activity in vitro
    Chakrabarti, G
    Basu, A
    Manna, PP
    Bhattacharya, S
    Sen, S
    Bandyopadhyay, S
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1996, 90 (05) : 582 - 585
  • [26] Interleukin 2 is an Upstream Regulator of CD4+ T Cells From Visceral Leishmaniasis Patients With Therapeutic Potential
    Chauhan, Shashi Bhushan
    Faleiro, Rebecca
    Kumar, Rajiv
    Ng, Susanna
    Singh, Bhawana
    Singh, Om Prakash
    Singh, Siddharth Sankar
    Amante, Fiona
    Rivera, Fabian de Labastida
    Rai, Madhukar
    Chakravarty, Jaya
    Sacks, David
    Nylen, Susanne
    Sundar, Shyam
    Engwerda, Christian
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (01) : 163 - 173
  • [27] Aberrant expression of T cell activation markers and upregulation of Tregs in bone marrow and peripheral blood in acute myeloid leukemia patients
    Fang, Junyue
    Zhang, Ruihao
    Lin, Xianghua
    Xu, Ying
    Huang, Kezhi
    Saw, Phei Er
    HEMATOLOGY, 2023, 28 (01)
  • [28] Investigation of typhlitis in bone marrow transplant patients in a stem cell transplant unit
    Deveci, Burak
    Kublashvili, George
    Yilmaz, Saim
    Ozcan, Baris
    Korkmaz, Halil Fatih
    Gursoy, Olcay
    Toptas, Tayfur
    Dosemeci, Levent
    Saba, Rabin
    MEDICINE, 2022, 101 (34) : E30104
  • [29] Leishmania donovani nucleoside hydrolase (NH36) Domains induce T-cell cytokine responses in human Visceral leishmaniasis
    Barbosa Santos, Micheli Luize
    Nico, Dirlei
    de Oliveira, Fabricia Alvisi
    Barreto, Aline Silva
    Palatnik-de-Sousa, Iam
    Carrillo, Eugenia
    Moreno, Javier
    de Luca, Paula Mello
    Morrot, Alexandre
    Rosa, Daniela Santoro
    Palatnik, Marcos
    Bani-Correa, Cristiane
    de Almeida, Roque Pacheco
    Palatnik-de-Sousa, Clarisa Beatriz
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [30] Bone marrow T-cell percentage: A novel prognostic indicator in acute myeloid leukemia
    Ismail, Manar M.
    Abdulateef, Nahla A. B.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (04) : 453 - 464